Núñez, L.M.; Benito, A.R.; Bereciartua, E.; Morata, L.; Escudero-Sánchez, R.; Nadal, J.S.; Gómez-Junyent, J.; Botrán, A.S.; García, A.M.A.; del Toro López, M.D.;
et al. Real-World Use of Dalbavancin in Diabetic Foot Osteomyelitis: PEDDAL Study. J. Clin. Med. 2025, 14, 6705.
https://doi.org/10.3390/jcm14196705
AMA Style
Núñez LM, Benito AR, Bereciartua E, Morata L, Escudero-Sánchez R, Nadal JS, Gómez-Junyent J, Botrán AS, García AMA, del Toro López MD,
et al. Real-World Use of Dalbavancin in Diabetic Foot Osteomyelitis: PEDDAL Study. Journal of Clinical Medicine. 2025; 14(19):6705.
https://doi.org/10.3390/jcm14196705
Chicago/Turabian Style
Núñez, Leonor Moreno, Ana Rueda Benito, Elena Bereciartua, Laura Morata, Rosa Escudero-Sánchez, Julia Sellares Nadal, Joan Gómez-Junyent, Alejandro Salinas Botrán, Ana María Arnáiz García, María Dolores del Toro López,
and et al. 2025. "Real-World Use of Dalbavancin in Diabetic Foot Osteomyelitis: PEDDAL Study" Journal of Clinical Medicine 14, no. 19: 6705.
https://doi.org/10.3390/jcm14196705
APA Style
Núñez, L. M., Benito, A. R., Bereciartua, E., Morata, L., Escudero-Sánchez, R., Nadal, J. S., Gómez-Junyent, J., Botrán, A. S., García, A. M. A., del Toro López, M. D., Ruiz-Cabrera, D., Andrino, J. M. R., Alidrous, F., Torío-Salvador, M., Verdejo, M. Á., & Velasco Arribas, M.
(2025). Real-World Use of Dalbavancin in Diabetic Foot Osteomyelitis: PEDDAL Study. Journal of Clinical Medicine, 14(19), 6705.
https://doi.org/10.3390/jcm14196705
